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A 79‐year‐old man was referred to our hospital because of persistent sore throat, dysphagia, and shortness of breath over the past two months. Physical examination of the oral cavity revealed bilateral tonsillar hypertrophy resulting in the near‐complete obstruction of the upper airway (Figure [1](#ccr32418-fig-0001){ref-type="fig"}A) and disseminated skin nodules (Figure [1](#ccr32418-fig-0001){ref-type="fig"}B). A total‐body computed tomography confirmed tonsillar enlargement (Figure [1](#ccr32418-fig-0001){ref-type="fig"}C), and widespread lymphadenopathy both above and below the diaphragm. Cell blood count showed leukocytosis WBC 44.000/μL, and flow cytometric analysis of bone marrow cells (Figure [1](#ccr32418-fig-0001){ref-type="fig"}D) identified an abnormal T‐cell population expressing TCR α/β, CD2, CD3, CD4, CD5, CD7, and CD52. Cytogenetics confirmed a complex karyotype including an inversion of chromosome 14. These findings were indicative of T‐cell prolymphocytic leukemia (T‐PLL). Bone marrow biopsy (Figure [1](#ccr32418-fig-0001){ref-type="fig"}E) and histological analysis of tonsillectomy specimen (Figure [1](#ccr32418-fig-0001){ref-type="fig"}F) confirmed the T‐PLL lymphoid infiltrate.

![A, Bilateral tonsillar enlargement secondary to T‐cell prolymphocytic leukemia cells (T‐PLL) infiltration. B, Nodular skin infiltration. C, Axial contrast‐enhanced CT scan shows bilateral palatine tonsils enlargement. D, Bone marrow (BM) aspirate morphology showing T‐PLL cells. E, BM biopsy shows an abnormal lymphocytic infiltrate. F, Epithelium of tonsil showing diffuse infiltration of T‐PLL](CCR3-7-2250-g001){#ccr32418-fig-0001}

T‐PLL is an aggressive cancer characterized by the hyperproliferation of post‐thymic prolymphocytes. T‐PLL accounts for \~2% of mature lymphocytic leukemias in adults.[1](#ccr32418-bib-0001){ref-type="ref"} The majority of patients present with nodal involvement (58%), and splenomegaly is among the most common physical finding (38%).[2](#ccr32418-bib-0002){ref-type="ref"} Skin lesions, including nodules, maculopapular rashes, or more rarely erythroderma, are described in \~20% of patients.[2](#ccr32418-bib-0002){ref-type="ref"} T‐PLL is usually resistant to conventional chemotherapy, and complete remissions are rare including the one achieved with alemtuzumab‐based regimens.[3](#ccr32418-bib-0003){ref-type="ref"}

Because of patients' life‐threatening condition, age, and severe risk of alemtuzumab infusion‐associated reactions, we initially tried cytoreducing the disease with age‐adjusted chemotherapy based on cyclophosphamide, vincristine, and high‐dose prednisone followed by the administration of 400 mg venetoclax for a month.[4](#ccr32418-bib-0004){ref-type="ref"}

However, after an initial response, we observed a worsening of clinical conditions that prompted surgical excision that improved the burden of the oral symptoms. While T‐PLL cutaneous infiltration is frequently observed in this disease, this is the first report describing a bilateral tonsillar involvement.
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